Source author record

Dristi Datta

Dristi Datta appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

1works
1topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2026arXiv

A Sparse-Attention Deep Learning Model Integrating Heterogeneous Multimodal Features for Parkinson's Disease Severity Profiling

Characterising the heterogeneous presentation of Parkinson's disease (PD) requires integrating biological and clinical markers within a unified predictive framework. While multimodal data provide complementary information, many existing computational models struggle with interpretability, class imbalance, or effective fusion of high-dimensional imaging and tabular clinical features. To address these limitations, we propose the Class-Weighted Sparse-Attention Fusion Network (SAFN), an interpretable deep learning framework for robust multimodal profiling. SAFN integrates MRI cortical thickness, MRI volumetric measures, clinical assessments, and demographic variables using modality-specific encoders and a symmetric cross-attention mechanism that captures nonlinear interactions between imaging and clinical representations. A sparsity-constrained attention-gating fusion layer dynamically prioritises informative modalities, while a class-balanced focal loss (beta = 0.999, gamma = 1.5) mitigates dataset imbalance without synthetic oversampling. Evaluated on 703 participants (570 PD, 133 healthy controls) from the Parkinson's Progression Markers Initiative using subject-wise five-fold cross-validation, SAFN achieves an accuracy of 0.98 plus or minus 0.02 and a PR-AUC of 1.00 plus or minus 0.00, outperforming established machine learning and deep learning baselines. Interpretability analysis shows a clinically coherent decision process, with approximately 60 percent of predictive weight assigned to clinical assessments, consistent with Movement Disorder Society diagnostic principles. SAFN provides a reproducible and transparent multimodal modelling paradigm for computational profiling of neurodegenerative disease.